CoChat

Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation

Open access
Baca, Sylvan C., Singler, Cassandra, Zacharia, Soumya, Seo, Ji-Heui, Morova, Tunc, Hach, Faraz, Ding, Yi, Schwarz, Tommer, Huang, Chia-Chi Flora, Anderson, Jacob, Fay, André P., Kalita, Cynthia, Groha, Stefan, Pomerantz, Mark M., Wang, Victoria, Linder, Simon, Sweeney, Christopher J., Zwart, Wilbert, Lack, Nathan A., Pasaniuc, Bogdan, Takeda, David Y., Gusev, Alexander, Freedman, Matthew L. · 2022 · Nature Genetics
Cited by 64

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Abstract Methods that link genetic variation to steady-state gene expression levels, such as expression quantitative trait loci (eQTLs), are widely used to functionally annotate trait-associated variants, but they are limited in identifying context-dependent effects on transcription. To address this challenge, we developed the cistrome-wide association study (CWAS), a framework for nominating variants that impact traits through their effects on chromatin state. CWAS associates the genetic determinants of cistromes (e.g., the genome-wide profiles of transcription factor binding sites or histone modifications) with traits using summary statistics from genome-wide association studies (GWAS). We performed CWASs of prostate cancer and androgen-related traits, using a reference panel of 307 prostate cistromes from 165 individuals. CWAS nominated susceptibility regulatory elements or androgen receptor (AR) binding sites at 52 out of 98 known prostate cancer GWAS loci and implicated an additional 17 novel loci. We functionally validated a subset of our results using CRISPRi and in vitro reporter assays. At 28 of the 52 risk loci, CWAS identified regulatory mechanisms that are not observable via eQTLs, implicating genes with complex or context-specific regulation that are overlooked by current approaches that relying on steady-state transcript measurements. CWAS genes include transcription factors that govern prostate development such as NKX3-1, HOXB13, GATA2, and KLF5. Moreover, CWAS boosts discovery power in modestly sized GWAS, identifying novel genetic associations mediated through AR binding for androgen-related phenotypes, including resistance to prostate cancer therapy. CWAS is a powerful and biologically interpretable paradigm for studying variants that influence traits by affecting context-dependent transcriptional regulation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-022-01168-y

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Metadata

Authors
Baca, S. C., Singler, C., Zacharia, S., Seo, J.-H., Morova, T., Hach, F., Ding, Y., Schwarz, T., Huang, C.-C. F., Anderson, J., Fay, A. P., Kalita, C., Groha, S., Pomerantz, M. M., Wang, V., Linder, S., Sweeney, C. J., Zwart, W., Lack, N. A., Pasaniuc, B., Takeda, D. Y., Gusev, A., & Freedman, M. L.
Venue
Nature Genetics
Published
2022-09
Volume
54
Issue
9
Pages
1364-1375
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W4294904531
Cited by
64
References
34
FWCI
6.73
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation. https://app.cochat.ai/papers/10.1038/s41588-022-01168-y
The paper
Baca, S. C., Singler, C., Zacharia, S., Seo, J.-H., Morova, T., Hach, F., Ding, Y., Schwarz, T., Huang, C.-C. F., Anderson, J., Fay, A. P., Kalita, C., Groha, S., Pomerantz, M. M., Wang, V., Linder, S., Sweeney, C. J., Zwart, W., Lack, N. A., . . . Freedman, M. L. (2022). Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation. Nature Genetics. https://doi.org/10.1038/s41588-022-01168-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.